Display options
Cite
Wachamo D, Bonja F. Magnitude of Opportunistic Infections and Associated Factors Among HIV-Positive Adults on ART at Selected Public Hospitals in Sidama National Regional State, Southern Ethiopia. HIV AIDS (Auckl). 2020;12:479-487doi: 10.2147/HIV.S265274.
Wachamo, D., & Bonja, F. (2020). Magnitude of Opportunistic Infections and Associated Factors Among HIV-Positive Adults on ART at Selected Public Hospitals in Sidama National Regional State, Southern Ethiopia. HIV/AIDS (Auckland, N.Z.), 12479-487. https://doi.org/10.2147/HIV.S265274
Wachamo, Demelash, and Bonja, Fisseha. "Magnitude of Opportunistic Infections and Associated Factors Among HIV-Positive Adults on ART at Selected Public Hospitals in Sidama National Regional State, Southern Ethiopia." HIV/AIDS (Auckland, N.Z.) vol. 12 (2020): 479-487. doi: https://doi.org/10.2147/HIV.S265274
Wachamo D, Bonja F. Magnitude of Opportunistic Infections and Associated Factors Among HIV-Positive Adults on ART at Selected Public Hospitals in Sidama National Regional State, Southern Ethiopia. HIV AIDS (Auckl). 2020 Sep 28;12:479-487. doi: 10.2147/HIV.S265274. eCollection 2020. PMID: 33061659; PMCID: PMC7532037.
Copy Download .nbib Format: NLM
Share it on

HIV AIDS (Auckl). 2020 Sep 28;12:479-487. doi: 10.2147/HIV.S265274. eCollection 2020.

Magnitude of Opportunistic Infections and Associated Factors Among HIV-Positive Adults on ART at Selected Public Hospitals in Sidama National Regional State, Southern Ethiopia.

HIV/AIDS (Auckland, N.Z.)

Demelash Wachamo, Fisseha Bonja

Affiliations

  1. Department of Public Health, Hawassa College of Health Sciences, Hawassa, South Nations and Nationalities Peoples' Region, Ethiopia.
  2. Department of Medical Laboratory, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia.

PMID: 33061659 PMCID: PMC7532037 DOI: 10.2147/HIV.S265274

Abstract

BACKGROUND: Opportunistic infections are late complications of HIV infection due to the depletion of the immune system. It is a major public health problem and high morbidity AIDS patients die of AIDS-related infections in developing countries like Ethiopia. Identification of opportunistic infections (OIs) is important to develop a specific intervention. Therefore, the aim of this study was to assess the burden and associated factors of opportunistic infections.

METHODS: A facility-based cross-sectional study was conducted on 420 randomly selected HIV/AIDS patients taking anti-retroviral therapy. Data were collected from selected hospitals in Sidama Regional State based on population proportion to size. Data were collected by a pre-tested questionnaire and a pre-tested checklist from the medical records of patients. Data were entered and analyzed for descriptive and logistic regression models by SPSS v.23. The result declared as statistically significant at p < 0.05.

RESULTS: The magnitude of opportunistic infections was 39.6%. Major identified OIs were oral candidiasis 23.2%, recurrent bacterial pneumonia 21.5%, herpes zoster 6.3%, and pulmonary tuberculosis 6.0%. The magnitude of opportunistic associated with older age [AOR=3.50, 95% CI:1.85, 6.61], no formal education [AOR=4.54, 95% CI:1.81, 11.37], initial CD4 count less than 200 cells/mm3 [AOR=3.10, 95% CI:1.61, 5.96], who interrupt ART medicines [AOR=3.21, 95% CI:1.86, 5.56] and khat chewing [AOR=4.24, 95% CI:2.07, 8.68] when compared to their counterparts.

CONCLUSION: The overall magnitude of opportunistic infections was high when compared with other studies. Health officials and clinicians need to give attention to the strengthening of the provision if ART with prophylaxis on early stage and adherence, implementation of the TB/HIV collaboration activity, and early initiation of ART to reduce opportunistic infections.

© 2020 Wachamo and Bonja.

Keywords: Ethiopia; HIV/AIDS; Sidama; WHO clinical stage; opportunistic infection

Conflict of interest statement

The authors declare that they have no conflict of interests for this work.

References

  1. Front Pharmacol. 2017 Nov 23;8:831 - PubMed
  2. J Int AIDS Soc. 2017;20(Suppl 5):22253 - PubMed
  3. BMC Infect Dis. 2015 Apr 17;15:187 - PubMed
  4. BMJ Glob Health. 2016 Dec 30;1(4):e000125 - PubMed
  5. Ann Intensive Care. 2016 Jun;6(Suppl 1):50 - PubMed
  6. PLoS One. 2017 Dec 21;12(12):e0189322 - PubMed
  7. J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):603-14 - PubMed
  8. BMC Res Notes. 2013 Dec 14;6:534 - PubMed
  9. HIV AIDS (Auckl). 2015 May 12;7:137-44 - PubMed
  10. Lancet. 2016 Apr 2;387(10026):1427-1480 - PubMed
  11. Cochrane Database Syst Rev. 2017 Sep 12;9:CD011086 - PubMed
  12. Jpn J Infect Dis. 2006 Oct;59(5):311-6 - PubMed
  13. J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21112 - PubMed
  14. Curr HIV/AIDS Rep. 2012 Dec;9(4):287-312 - PubMed
  15. BMC Res Notes. 2016 Dec 7;9(1):501 - PubMed
  16. AIDS Res Ther. 2013 Feb 25;10(1):7 - PubMed

Publication Types